EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators

Halime Nayır Büyükşahin iD, Nagehan Emiralioğlu iD, Ebru Yalçın, Velat Şen, Hadice Selimoğlu Şen, Hüseyin Arslan, Azer Kılıç Başkan, Fatma Betül Çakır, Cem Fırat Koray, Aslı İmran Yılmaz, Fatih Ercan, Derya Ufuk Altıntaş und 43 weitere

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.27051 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Halime Nayır Büyükşahin und 54 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cystic fibrosis transmembrane conductance regulator (CFTR) modulator drugs target the underlying defect and improve CFTR function. They are a part of standard care in many countries, but not all patients are eligible for these drugs due to age and genotype. Here, we aimed to determine the characteristics of non‐eligible patients for CFTR modulators in the CF registry of Turkey (CFRT) to highlight their clinical needs.

Methods

This retrospective cohort study included CF patient data from the CFRT in 2021. The decision of eligibility for the CFTR modulator was determined according to the ‘Vertex treatment‐Finder' on the Vertex® website. Demographic and clinical characteristics of patients were compared between eligible (group 1) and ineligible (group 2) groups for CFTR modulators.

Results

Among the study population ( N = 1527), 873 (57.2%) were in group 1 and 654 (42.8%) were in group 2. There was no statistical difference between groups regarding sex, meconium ileus history, diagnoses via newborn screening, FEV1 z‐score, CF‐associated complications, organ transplant history, and death. Patients in group 2 had a higher incidence of pancreatic insufficiency (87.7% vs. 83.2%, p = .010), lower median height z‐scores (−0.87 vs. −0.55, p < .001), lower median body mass index z‐scores (−0.65 vs. −0.50, p < .001), longer days receiving antibiotics due to pulmonary exacerbation (0 [interquartile range, IQR: 0–2] vs. 0 [IQR: 0–7], p = 0.001), and more non‐invasive ventilation support (2.6% vs. 0.9%, p = 0.008) than patients in group 1.

Conclusion

The ineligible group had worse clinical outcomes than the eligible group. This highlights their need for life‐changing drugs to improve clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansFemaleMaleRetrospective StudiesChildAdolescentTurkeyChild, PreschoolRegistriesInfantYoung AdultExocrine Pancreatic InsufficiencyInfant, NewbornPatient Selection

Stichwörter der Autor:innen

CFTR modulatorsclinical featurescystic fibrosiseligibilityregistry

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Division of Pulmonology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Division of Pulmonology, Department of Pediatrics, Dicle University Faculty of Medicine, Diyarbakır, Turkey.
  • Department of Pulmonology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.
  • Division of Pediatric Allergy and Pulmonology, Department of Pediatrics, Cerrahpaşa Medicine Faculty, Istanbul University, Istanbul, Turkey.
  • Division of Pediatric Pulmonology, Faculty of Medicine, Bezmialem University, Istanbul, Turkey.
  • Division of Pediatric Pulmonology, Meram Medicine Faculty, Necmettin Erbakan University, Konya, Turkey.

ORCID-Profile: Halime Nayır Büyükşahin, Nagehan Emiralioğlu, Elif Arık, Oğuz Karcıoğlu, Ali Özdemir, Şule Selin Soydaş, Melih Hangül, Gizem Özcan, Gökçen Kartal Öztürk, Beste Özsezen, Mina Hızal, Hakan Yazan, Erkan Çakır, Tuğba Şişmanlar Eyüboğlu, Nazan Çobanoğlu, Güzin Cinel, Sevgi Pekcan, Deniz Doğru

Förderung

  • None

Zitieren

APA

Nayır Büyükşahin, H., Emiralioğlu, N., Yalçın, E., Şen, V., Selimoğlu Şen, H., Arslan, H., Başkan, A. K., Çakır, F. B., Koray, C. F., Yılmaz, A. İ., Ercan, F., Altıntaş, D. U., Serbes, M., Keskin, Ö., Arık, E., Gülen, F., Barlık, M., Karcıoğlu, O., Damadoğlu, E., …, & Doğru, D. (2024). Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27051

Vancouver

Nayır Büyükşahin H, Emiralioğlu N, Yalçın E, Şen V, Selimoğlu Şen H, Arslan H, et al. Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27051

BibTeX
@article{NayrBykahin2024,
  author = {Nayır Büyükşahin, Halime and Emiralioğlu, Nagehan and Yalçın, Ebru and Şen, Velat and Selimoğlu Şen, Hadice and Arslan, Hüseyin and Başkan, Azer Kılıç and Çakır, Fatma Betül and Koray, Cem Fırat and Yılmaz, Aslı İmran and Ercan, Fatih and Altıntaş, Derya Ufuk and Serbes, Mahir and Keskin, Özlem and Arık, Elif and Gülen, Figen and Barlık, Meral and Karcıoğlu, Oğuz and Damadoğlu, Ebru and Köse, Mehmet and Ersoy, Ali and Bingöl, Ayşen and Başaran, Erdem and Çakır, Eylül Pınar and Aslan, Ayşe Tana and Canıtez, Yakup and Korkmaz, Merve and Özdemir, Ali and Harmancı, Koray and Soydaş, Şule Selin and Hangül, Melih and Yüksel, Hasan and Özcan, Gizem and Korkmaz, Pervin and Kılıç, Mehmet and Gayretli Aydın, Zeynep Gökçe and Çaltepe, Gönül and Can, Demet and Doğru, Sibel and Kartal Öztürk, Gökçen and Süleyman, Ayşe and Topal, Erdem and Özsezen, Beste and Hızal, Mina and Demirdöğen, Ezgi and Ogun, Hamza and Börekçi, Şermin and Yazan, Hakan and Çakır, Erkan and Şişmanlar Eyüboğlu, Tuğba and Çobanoğlu, Nazan and Cinel, Güzin and Pekcan, Sevgi and Özçelik, Uğur and Doğru, Deniz},
  title = {Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.27051}
}
Kostenlos starten →